Cyprus
Diabetes country report 2000 — 2050
Number of adults (20–79 years) with diabetes in Cyprus (CY)
2000 | 25.3 thousand |
2011 | 81.8 thousand |
2024 | 106.1 thousand |
2050 | 140.0 thousand |
Cyprus is one of the 60 countries and territories in the IDF Europe Region.
Data source(s) used for the diabetes estimates in adults:
- Loizou T, Pouloukas S, Tountas C, Thanopoulou A, Karamanos V. Diabetes Care. 2006 Jul;29(7):1714-5. PMID: 16801614
Diabetes estimates (20-79 y) | ||||
---|---|---|---|---|
People with diabetes, in 1,000s | 25.3 | 81.8 | 106.1 | 140.0 |
Age-standardised prevalence of diabetes, % | - | 9.3 | 10.0 | 11.3 |
Proportion of people with undiagnosed diabetes, % | - | - | 36.6 | - |
People with undiagnosed diabetes, in 1,000s | - | - | 38.8 | - |
Impaired Fasting Glucose (IFG) | ||||
---|---|---|---|---|
People with IFG, in 1,000s | - | - | 77.2 | 90.8 |
Age-standardised prevalence of IFG, % | - | - | 7.6 | 8.0 |
Impaired Glucose Tolerance (IGT) | ||||
---|---|---|---|---|
People with IGT, in 1,000s | - | 53.0 | 66.4 | 85.8 |
Age-standardised prevalence of IGT, % | - | 6.1 | 6.3 | 7.0 |
Mortality attributable to diabetes (20-79 y) | ||||
---|---|---|---|---|
Deaths attributable to diabetes | - | 456.0 | 741.9 | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - | - | 16.3 | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||
---|---|---|---|---|
Live births affected by HIP | - | - | - | - |
Prevalence of gestational diabetes mellitus (GDM), % | - | - | - | - |
Live births affected by other types of diabetes first detected in pregnancy | - | - | - | - |
Live births affected by other types of diabetes detected prior to pregnancy | - | - | - | - |
Diabetes-related health expenditure | ||||
---|---|---|---|---|
Total diabetes-related health expenditure, USD million | - | - | 244.9 | 253.8 |
Total diabetes-related health expenditure, ID million | - | - | 328.9 | 340.9 |
Diabetes-related health expenditure per person, USD | - | 2,162.0 | 2,307.6 | 1,813.0 |
Diabetes-related health expenditure per person, ID | - | - | 3,099.2 | 2,434.9 |
Type 1 diabetes estimates in children and adolescents | ||||
---|---|---|---|---|
People with type 1 diabetes (all age groups) | - | - | 2,984.0 | - |
People with type 1 diabetes (0-19 y) | - | - | 309.2 | - |
Demographics | ||||
---|---|---|---|---|
Total adult population (20-79 y), in 1,000s | 518.0 | 809.0 | 957.6 | 1,044.9 |
Population of children and adolescents (0-19 y) | - | - | 285,454.0 | - |
Diabetes estimates (20-79 y) | |
---|---|
People with diabetes, in 1,000s | 25.3 |
Age-standardised prevalence of diabetes, % | - |
Proportion of people with undiagnosed diabetes, % | - |
People with undiagnosed diabetes, in 1,000s | - |
Impaired Fasting Glucose (IFG) | |
---|---|
People with IFG, in 1,000s | - |
Age-standardised prevalence of IFG, % | - |
Impaired Glucose Tolerance (IGT) | |
---|---|
People with IGT, in 1,000s | - |
Age-standardised prevalence of IGT, % | - |
Mortality attributable to diabetes (20-79 y) | |
---|---|
Deaths attributable to diabetes | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | |
---|---|
Live births affected by HIP | - |
Prevalence of gestational diabetes mellitus (GDM), % | - |
Live births affected by other types of diabetes first detected in pregnancy | - |
Live births affected by other types of diabetes detected prior to pregnancy | - |
Diabetes-related health expenditure | |
---|---|
Total diabetes-related health expenditure, USD million | - |
Total diabetes-related health expenditure, ID million | - |
Diabetes-related health expenditure per person, USD | - |
Diabetes-related health expenditure per person, ID | - |
Type 1 diabetes estimates in children and adolescents | |
---|---|
People with type 1 diabetes (all age groups) | - |
People with type 1 diabetes (0-19 y) | - |
Demographics | |
---|---|
Total adult population (20-79 y), in 1,000s | 518.0 |
Population of children and adolescents (0-19 y) | - |